Peter Lassoff is Vice President and Head of Global Regulatory Affairs at Quintiles. In his role, he works with global clients in the pharmaceutical, medical device, cosmetic, nutrition and other industries on regulatory strategy and implementation to ensure their products are placed on the market in the fastest, least expensive manner. Dr. Lassoff has deep expertise in the development and worldwide registration of medicinal products, biotech products, ‘borderline’ products, medical devices, cosmetics and ‘cosmeceuticals’, nutritional supplements and other regulated healthcare products.
He has registered hundreds of products in Europe, the United States and global markets, including joint NDA/Centralised EMA submissions. He provides regulatory strategies for the development of products for global markets from preclinical to post-marketing as well as expert regulatory due diligence services for companies purchasing products or companies.
In addition, Dr. Lassoff has a strong understanding of the value of generics to public health through his long experience with the generics industry. His experience includes working with large pharmaceutical companies to develop strategic go-to-market plans to leverage the demand for branded generics, as well as creating innovative solutions for over-the-counter and hybrid products.
Dr. Lassoff has worked in the pharmaceutical industry for 30 years. Prior to joining Quintiles, he held other leadership positions in the CRO field, and has held previous positions at BMS, ConvaTec and Stiefel.
Dr. Lassoff holds a Doctor of Pharmacy (PharmD) from the University of Southern California School of Pharmacy.